文献速递胃肠外科肝胆胰外科围术期管理与 ERAS

腹腔镜经腹膜与腹膜后入路切除良性腹膜后肿瘤的安全性与疗效比较:一项回顾性队列研究

Safety and efficacy of laparoscopic transperitoneal versus retroperitoneal resection for benign retroperitoneal tumors: a retrospective cohort study.
PubMed 文献 · Surg Endosc · 2023-10-26

该单中心回顾性队列研究分析了2019年1月至2022年5月43例病理确诊良性腹膜后肿瘤并接受腹腔镜切除的患者,经腹膜入路组24例、腹膜后入路组19例。两组在性别、年龄、体质指数、美国麻醉医师学会评分、基础疾病、肿瘤大小、肿瘤位置、手术时间、术中出血、术后住院时间、肠道功能恢复时间及术后并发症发生率方面均无显著差异。经腹膜入路组中转开腹率显著低于腹膜后入路组(1/24 vs. 5/19,χ2=4.333,P=0.037)。肿瘤大小是手术效果的独立影响因素(比值比=1.869,95%置信区间=1.135-3.078,P=0.014),且对腹膜后入路组影响更大(比值比=3.740,95%置信区间=1.044-13.394,P=0.043)。作者认为经腹膜入路可能疗效更优,尤其适用于大肿瘤或肿瘤邻近重要血管的情况。

要点

  • 经腹膜入路组中转开腹率显著低于腹膜后入路组(1/24 vs. 5/19,χ2=4.333,P=0.037)。
  • 两组在手术时间、术中出血、术后住院时间、肠道功能恢复及并发症率方面无显著差异。
  • 肿瘤大小是手术效果的独立影响因素(比值比=1.869,95%置信区间=1.135-3.078,P=0.014),对腹膜后入路组影响更大(比值比=3.740,95%置信区间=1.044-13.394,P=0.043)。

核心结论

  • 腹腔镜经腹膜入路具有解剖层次和手术空间的固有优势,能提供更好的目标肿块光学视野和更好的出血控制。
  • 作者认为经腹膜入路可能比腹膜后入路疗效更优,尤其在大肿瘤或肿瘤邻近重要血管的情况下。

研究设计与样本

  • 单中心回顾性队列研究,纳入2019年1月至2022年5月病理确诊良性腹膜后肿瘤并接受腹腔镜切除的患者43例。
  • 按手术方式分为经腹膜入路组(n=24)和腹膜后入路组(n=19),比较两组临床特征和围术期数据。

主要发现

  • 两组在性别、年龄、体质指数、美国麻醉医师学会评分、基础疾病、肿瘤大小、肿瘤位置、手术时间、术中出血、术后住院时间、肠道功能恢复时间及术后并发症发生率方面均无显著差异。
  • 经腹膜入路组中转开腹率显著低于腹膜后入路组(1/24 vs. 5/19,χ2=4.333,P=0.037)。
  • 肿瘤大小是手术效果的独立影响因素(比值比=1.869,95%置信区间=1.135-3.078,P=0.014),且对腹膜后入路组影响更大(比值比=3.740,95%置信区间=1.044-13.394,P=0.043)。

临床怎么用

  • 作者认为经腹膜入路可能具有更好的疗效,尤其适用于大肿瘤或肿瘤邻近重要血管的情况。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Benign retroperitoneal tumors (BRTs) are clinically rare solid tumors. This study aimed to compare the safety and efficacy of laparoscopic transperitoneal versus retroperitoneal resection for BRTs. METHODS: The clinical data of 43 patients who had pathologically confirmed BRTs and underwent laparoscopic resection in a single center from January 2019 to May 2022 were retrospectively analyzed. Patients were divided into two groups according to the surgical methods: the Transperitoneal approach group (n = 24) and the Retroperitoneal approach group (n = 19). The clinical characteristics and perioperative data between the two groups were compared. The baseline data and surgical variables were analyzed to determine the impact of different surgical approaches on the treatment outcomes of BRTs. RESULTS: No significant difference was observed between the two groups in gender, age, body mass index, the American Society of Anesthesiologists score, presence of underlying diseases, tumor size, tumor position, operation duration, intraoperative hemorrhage, postoperative hospital stay, intestinal function recovery time, and postoperative complication rate. The conversion rate from laparoscopic to open surgery was significantly lower in the Transperitoneal approach group than in the Retroperitoneal approach group (1/24 vs. 5/19, χ2 = 4.333, P = 0.037). Tumor size was an independent influencing factor for the effect of surgery (odds ratio = 1.869, 95% confidence interval = 1.135-3.078, P = 0.014) and had a larger efficacy on the retroperitoneal group (odds ratio = 3.740, 95% confidence interval = 1.044-13.394, P = 0.043). CONCLUSION: The laparoscopic transperitoneal approach has the inherent advantages of anatomical hierarchies and surgical space, providing a better optical perspective of the targeted mass and improved bleeding control. This approach may have better efficacy than the retroperitoneal approach, especially in cases of a large tumor or when the tumor is located near important blood vessels.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Hou Z, Xie Q, Qiu G, et al. Safety and efficacy of laparoscopic transperitoneal versus retroperitoneal resection for benign retroperitoneal tumors: a retrospective cohort study. Surg Endosc. 2023. PMID: 37884734. doi:10.1007/s00464-023-10504-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。